Close Menu

NEW YORK (GenomeWeb) – DiaSorin and the Tecan Group today announced a collaboration to develop a nucleic acid extraction platform.

Financial and other terms of the deal were not disclosed.

The new platform will leverage Tecan's Fluent Laboratory Automation Solution along with DiaSoriin's Liaison MDX PCR system to provide users a complete sample-to-result system, the firms said, adding the Fluent instrument will be optimized for use with DiaSorin's extraction chemistry and automated PCR technology.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Wall Street Journal reports that Russia's announcement of a coronavirus vaccine approval was met with concern as safety testing has not yet been completed.

New Scientist writes there aren't much data available on the accuracy of the two rapid COVID-19 tests the UK plans to roll out.

In PNAS this week: downstream effect of oncoprotein fusion, epigenetic changes influence tRNAs in colon cancer, and more.

Nature News reports that recent proposed changes to the US National Science Foundation have raised concerns about a shift away from the agency's focus on basic research.